Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 11, 2023
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2023
Oct. 31, 2022
Dec. 31, 2023
Intangible assets   $ 3,549,427   $ 3,549,427    
Impairment on intangible assets       0 $ 0  
Impairment charges       $ 0 0  
Stock Repurchased During Period, Shares 8,085,879 78,109   8,163,988    
Payments for Repurchase of Common Stock   $ 164,953   $ 26,622,277 5,475,891  
Accrual for Taxes Other than Income Taxes, Current   266,223   266,223    
Research and Development Expense   82,033 $ 177,996 186,516 337,269  
Federal deposit insurance amount   250,000   250,000    
Aggregate uninsured balance   24,264,000 $ 1,060,000 24,264,000 $ 1,060,000  
Cell In A Box [Member]            
Intangible assets   1,549,427   1,549,427    
Diabetes License [Member]            
Intangible assets   $ 2,000,000   $ 2,000,000    
S G Austria [Member]            
Equity Method Investment, Ownership Percentage           14.30%